Your browser doesn't support javascript.
loading
Risk factors and 26-years worldwide prevalence of endoscopic erosive esophagitis from 1997 to 2022: a meta-analysis.
Witarto, Andro Pramana; Witarto, Bendix Samarta; Pramudito, Shidi Laras; Ratri, Lintang Cahyaning; Wairooy, Nabilah Azzah Putri; Konstantin, Tiffany; Putra, Achmad Januar Er; Wungu, Citrawati Dyah Kencono; Mufida, Annisa Zahra; Gusnanto, Arief.
Afiliação
  • Witarto AP; Medical Program, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.
  • Witarto BS; Medical Program, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.
  • Pramudito SL; Medical Program, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.
  • Ratri LC; Medical Program, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.
  • Wairooy NAP; Medical Program, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.
  • Konstantin T; Medical Program, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.
  • Putra AJE; Medical Program, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.
  • Wungu CDK; Department of Physiology and Medical Biochemistry, Universitas Airlangga, Jl. Mayjen Prof. Dr. Moestopo No. 47, Surabaya, 60132, Indonesia. citrawati.dyah@fk.unair.ac.id.
  • Mufida AZ; Institute of Tropical Disease, Universitas Airlangga, Surabaya, Indonesia. citrawati.dyah@fk.unair.ac.id.
  • Gusnanto A; Department of Internal Medicine, Dr. Soetomo General Hospital, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.
Sci Rep ; 13(1): 15249, 2023 09 14.
Article em En | MEDLINE | ID: mdl-37709957
ABSTRACT
Erosive esophagitis (EE) is the part of gastroesophageal reflux disease (GERD) spectrum and may progress to esophageal adenocarcinoma. Due to its progressivity and unclear prevalence, we aim to identify the factors contributing in EE to decide the need for further examination. We performed a PRISMA 2020-based systematic search through PubMed and other resources up to June 2, 2022. Study quality was assessed using the Newcastle-Ottawa Scale (NOS). The odds ratio (OR) of each factor and worldwide prevalence of EE were measured. There are 114 observational studies included with a total of 759,100 participants. Out of 29 factors, the significant risk factors are age ≥ 60 y.o. (OR 2.03 [1.81-2.28]), White/Caucasian (OR 1.67 [1.40-1.99]), unmarried (OR 1.08 [1.03-1.14]), having GERD ≥ 5 years (OR 1.27 [1.14-1.42]), general obesity (OR 1.78 [1.61-1.98]), central obesity (OR 1.29 [1.18-1.42]), diabetes mellitus (DM) (OR 1.24 [1.17-1.32]), hypertension (OR 1.16 [1.09-1.23]), dyslipidemia (OR 1.15 [1.06-1.24]), hypertriglyceridemia (OR 1.42 [1.29-1.57]), hiatal hernia (HH) (OR 4.07 [3.21-5.17]), and non-alcoholic fatty liver disease (NAFLD) (OR 1.26 [1.18-1.34]). However, H. pylori infection (OR 0.56 [0.48-0.66]) and atrophic gastritis (OR 0.51 [0.31-0.86]) are protective towards EE. This study demonstrates that age, ethnicity, unmarried, long-term GERD, metabolic diseases, HH, and NAFLD act as risk factors for EE, whereas H. pylori infection and atrophic gastritis act as protective factors. These findings may enable a better understanding of EE and increase greater awareness to address its growing burden.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Refluxo Gastroesofágico / Esofagite / Hepatopatia Gordurosa não Alcoólica / Gastrite Atrófica / Hérnia Hiatal Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Refluxo Gastroesofágico / Esofagite / Hepatopatia Gordurosa não Alcoólica / Gastrite Atrófica / Hérnia Hiatal Idioma: En Ano de publicação: 2023 Tipo de documento: Article